A Non-Interventional Clinical Study to Assess the Risk and Performance Aspects of Olynth Saline/Ectomed Nasal Drops/Spray Based Upon Previous Usage
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 87
- 试验地点
- 1
- 主要终点
- Participant Feedback on the Performance Aspects of Olynth Nasal Saline Spray
研究概览
简要总结
The purpose of this study is to proactively collect customer feedback on the performance aspects and risk factors of Olynth Nasal Saline Drops/Spray and Olynth Ectomed Nasal Spray.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Aged 18 years or older who has personally used or administered the nasal drops/spray to a child
- •Has personally used or administered to a child, the Nasal Drops/Spray at least once within the past 6 months
- •Able to read, write, speak, and understand German
- •Has internet access to complete an on-line survey
- •Intends to complete the survey
- •Individual has signed the informed consent document (ICD)
排除标准
- •Is an employee/contractor or immediate family member of the principal investigator (PI), Schlesinger group, product perceptions limited (PPL) Insights or sponsor of this study
结局指标
主要结局
Participant Feedback on the Performance Aspects of Olynth Nasal Saline Spray
时间窗: Up to 1 month and 14 days
Participant feedback on the performance aspects of Olynth Nasal Saline Spray will be assessed via electronic survey.
Participant Feedback on the Performance Aspects of Olynth Ectomed Nasal Spray
时间窗: Up to 1 month and 14 days
Participant feedback on the performance aspects of Olynth Ectomed Nasal Spray will be assessed via electronic survey.
Participant Feedback on the Performance Aspects of Olynth Nasal Saline Drops
时间窗: Up to 1 month and 14 days
Participant feedback on the performance aspects of Olynth Nasal Saline Drops will be assessed via electronic survey.
Number of Participants with Adverse Events (AEs)
时间窗: Up to 1 month and 14 days
An AE is any untoward medical occurrence, unintended disease or injury or any untoward clinical signs, including an abnormal laboratory finding, in participants, users or other persons, whether or not related to the investigational device.
次要结局
未报告次要终点